153 related articles for article (PubMed ID: 8662105)
1. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies.
Aigner RM; Fueger GF; Nicoletti R
Eur J Nucl Med; 1996 Jun; 23(6):693-6. PubMed ID: 8662105
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid scintigraphy: first experiences with technetium (III)-99m-Q12.
Aigner RM; Fueger GF; Wolf G
Eur J Nucl Med; 1997 Mar; 24(3):326-9. PubMed ID: 9143473
[TBL] [Abstract][Full Text] [Related]
3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
8. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
9.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
10.
Huang Z; Lou C
J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
[TBL] [Abstract][Full Text] [Related]
13. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
Giordano A; Meduri G
Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
[No Abstract] [Full Text] [Related]
14. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
[TBL] [Abstract][Full Text] [Related]
16. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma.
Bénard F; Lefebvre B; Beuvon F; Langlois MF; Bisson G
J Nucl Med; 1995 Feb; 36(2):241-3. PubMed ID: 7830122
[TBL] [Abstract][Full Text] [Related]
17. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
20. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
